By 2020, the world of health care will be characterized by informed and empowered patients who want access to the best available treatment, at an affordable price. New therapeutic solutions for unmet medical needs will be developed through partnerships with industry, academia, government, health care professionals and patients.
In this environment, Janssen EMEA will lead a fundamental change in the way diseases are managed.
In our absolute commitment to patients, we will build innovative, integrated health care solutions that will restore and extend the quality of life, while creating economic value for society and our company.
We will achieve this by working side-by-side with health care stakeholders and by building on our people's talent.
Mission
We will focus our energy on five major therapeutic areas of unmet need:
- Neuroscience (schizophrenia, dementia, pain …),
- Infectious Diseases (HIV/AIDS, Hepatitis C, tuberculosis, …),
- Oncology (multiple myeloma, prostate cancer, …),
- Immunology (psoriasis, …),
- Metabolism (diabetes, …).
We use Our Credo values as our moral compass
We will develop sustainable, integrated health care solutions by working with patients, physicians and other stakeholders, based on partnerships of trust and transparency. We will continue to invest in our people to realize their personal growth and to build our leaders of the future.